Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,317,298
+$1,251,285 QoQ
Shares Held
1,932
+66.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.16%
of 13F equity value
Holder Rank
#2,359
of 4,605 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Darden Wealth Group Inc holds $5,302,155 across 5 Drug Manufacturers - General names. LLY ranks #1 (43.7% of the industry book) .
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,317,298 | 1,932 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,066,013 | 1,159 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,209,015 | 1,125 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $782,075 | 1,025 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,032,877 | 1,325 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,193,439 | 1,445 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,123,260 | 1,455 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,342,199 | 1,515 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,321,854 | 1,460 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,135,821 | 1,460 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $792,771 | 1,360 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||